ACSS3 and neoplasm: In the current study, we found that ACSS3/PLIN3-mediated LD elimination significantly reduced lipid/cholesterol contents in tumor cells, thus repressing intratumoral androgen synthesis, thereby inhibiting CRPC progression and Enzalutamide resistance.